Medtech Insight's 'Investment In Innovation' Conference, June 14-15, 2001, To Present Innovative Medical Technologies

Apr 24, 2001, 01:00 ET from Medtech Insight

    WASHINGTON, April 24 /PRNewswire Interactive News Release/ -- Medtech
 Insight, a respected provider of business information on new technologies and
 emerging companies in the medical industry, will be hosting a two-day
 conference, "Investment In Innovation (IN3): A Preview of Early Stage Medical
 Technologies" at Boston's Hyatt Harborside Hotel, June 14-15, 2001. More than
 50 mostly privately held medical technology companies will give presentations
 over the course of two days. Following each company's presentation, breakout
 rooms will be available for individual meetings with interested parties.
 Invited companies will present on a range of emerging medical technologies,
 including advanced cardiovascular and orthopedic materials, wound management,
 intraoperative imaging, spine surgery, medical simulation systems, tissue
 engineering and cell therapy, remote monitoring, wireless diagnostics,
 internet healthcare and other diagnostic and therapeutic technologies.
 Confirmed presenters to date include:
 
     *  Accuray Oncology -- stereotactic radiosurgery/radiotherapy for
        treatment of solid cancers
     *  A-Med Systems, Inc. -- circulatory support for cardiac surgery and
        interventions
     *  American OsteoMedix -- controlled delivery for osteoplasty
     *  Atherotech -- lipid panel for substantially improving the
        identification of cardiovascular disease risk
     *  Bacchus Vascular Inc. -- alternative techniques and devices for
        percutaneous venous and arterial thrombectomy
     *  BioHeart, Inc. --genotyping for heart muscle regeneration
     *  Boston Innovative Optics - innovative corneal implant compatible with
        LASIK
     *  Boston Medical Technologies, Inc. -- non-invasive method for testing
        heart rate variability
     *  Cardio-optics Inc. -- visualization technology to enable real-time
        imaging of tissues normally obscured by blood
     *  CardioStream Corporation -- diagnostic and therapeutic devices for
        detection and treatment of vulnerable plaque
     *  Converge Medical -- anastomotic coupling technology
     *  Corazon Technologies, Inc. -- demineralization techniques
     *  Cortek, Inc. -- lumbar and cervical spinal fusion technologies
     *  Cryovascular Systems, Inc. -- catheter system to prevent post
        angioplasty/stent placement coronary artery restenosis
     *  Derma Sciences -- wound management, wound closure and catheter
        securement
     *  Endologix -- minimally invasive stent technology for abdominal aortic
        aneurysm
     *  ExoGenesis Biomedical Corporation -- gas cluster ion beam processing
        for surface modification of implantable medical devices
     *  FireLogic, Inc. -- wireless applications for accelerating clinical
        trials and managing treatment outcomes
     *  First Circle Medical -- novel platform for treatment of Hepatitis C
     *  Fossa Industries, Inc. -- cost-effective management of urinary
        lithiasis
     *  Hamilton Thorne Biosciences -- reproductive cell analysis systems
     *  Hayes Medical, Inc. -- orthopaedic implant technologies
     *  IDev Technologies, Inc. -- minimally invasive interventional
        radiology/vascular surgery technologies
     *  ImPres Medical, Inc. -- platform technology for management of
        gynecologic disorders, including abnormal uterine bleeding
     *  Integrated Sensing Systems -- pressure and flow sensing systems for
        vascular and other applications
     *  Medical Simulation Corporation -- technology for interactive training
        of healthcare professionals in state-of-the-art medical procedures
     *  MedLink Europe -- medical device supply chain management
     *  Metasensors, Inc. -- diagnostic/monitoring products based on gas
        flowing in microfluidic elements
     *  MicroCHIPS, Inc. -- microchip devices for drug delivery and sensing
        applications
     *  Nervation Ltd. -- polyurethane-based vascular graft devices for the
        treatment of late-stage cardiovascular disease
     *  NeuroVision Inc. -- non-invasive neural treatments for improvement of
        vision
     *  Novadaq Technologies Inc. -- intraoperative cardiac monitoring
     *  Odin Medical Technologies -- intraoperative MRI systems for
        neurosurgery
     *  Osiris Therapeutics, Inc. -- stem cells used for cellular therapy for
        damaged and diseased tissues
     *  Percardia -- stent blood to ventricle alternative to coronary bypass
     *  PRISMedical Corporation -- disposable devices for point-of-use
        preparation and delivery of fluid therapies
     *  Replication Medical -- spinal nucleus replacement device
     *  Sensatex/LifeLink -- "SmartShirt"-a wireless device for remote
        monitoring
     *  Spectrasonics Imaging, Inc. -- high intensity focused ultrasound (HIFU)
        therapy and tissue parameter imaging
     *  Spine Solutions -- total disc replacement prosthesis
     *  Spine-issimus Ltd -- new technology for treatment of back, knee and
        arthritic pain
     *  SuturTek Incorporated -- "Safe-Suturing" closure technology
     *  Tensegra, Inc. -- artificial disc replacement
     *  Tissue Transformation Technologies -- cell-based in vitro models for
        research, drug metabolism, toxicity and compound screening
     *  TissueLink Medical, Inc. -- hemostasis and anastomosis device
     *  VenPro Corporation -- surgical and percutaneous management of chronic
        venous insufficiency
     *  VSM MedTech Ltd. -- devices for improved vital signs monitoring
     *  X-Site Medical, LLC -- arteriotomy closure system
     *  Yoreh Bio Ltd. -- platform technology for cancer diagnostics and
        therapeutics
 
     "The interests of business development, licensing, joint venture,
 acquisition and investment will be well served by attendance at this meeting,"
 reports Sharon O'Reilly, President of Medtech Insight. "The technologies of
 these innovative companies are at the right stage of development for lucrative
 partnering arrangements."
     The "Investment In Innovation" (IN3) conference, which is co-sponsored by
 Arthur Anderson Corporate Finance, Prism Venture Partners, Advanced Technology
 Ventures, Battelle Memorial Institute, MEDMARC, The Patterson Group, ZEVEX,
 and The MedTech Group, is designed for senior executives from the medical
 device and biotech industry, investment bankers and venture capitalists to
 gain exposure to early stage medical technology companies for the purpose of
 investment, acquisition and/or strategic partnering.
     Keynote presentations will be given by James E. Nicholson, Chairman & CEO,
 Cortek, Inc.; Founder, Mitek Surgical Products, Innovasive Devices, Cortek,
 Inc., and Winnipesaukee Investor Group (WIG), on "The Genesis of a Startup
 Medical Venture", and Sharon O'Reilly, President, Medtech Insight LLC, on
 "Medical Technology in the New Millennium." An additional keynote presenter
 will be announced at a later date.
     On-demand viewing of company presentations from Medtech Insight's January
 2001 "Investment In Innovation" conference can be purchased and accessed
 through the Medtech Insight website, at www.medtechinsight.com.
 
     Medtech Insight is the publisher of "Medtech Insight" (formerly
 "BioMaterials & Surgery"), a monthly newsletter designed to keep medical
 device executives up-to-date on the latest discoveries, trends and innovations
 in the medical device industry. The company also publishes analyses of medical
 technology markets through its Reports group, and provides utilization
 database and other content for the medical technology marketplace. For more
 information on Medtech Insight, please contact Scott Pantel at (714) 969-7648
 or by email at scott@medtechinsight.com, or visit the web at
 http://www.medtechinsight.com.  Details on the upcoming IN3 conference in
 Boston are available at http://www.medtechinsight.com/in3-02.html.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X37527478
 
 

SOURCE Medtech Insight
    WASHINGTON, April 24 /PRNewswire Interactive News Release/ -- Medtech
 Insight, a respected provider of business information on new technologies and
 emerging companies in the medical industry, will be hosting a two-day
 conference, "Investment In Innovation (IN3): A Preview of Early Stage Medical
 Technologies" at Boston's Hyatt Harborside Hotel, June 14-15, 2001. More than
 50 mostly privately held medical technology companies will give presentations
 over the course of two days. Following each company's presentation, breakout
 rooms will be available for individual meetings with interested parties.
 Invited companies will present on a range of emerging medical technologies,
 including advanced cardiovascular and orthopedic materials, wound management,
 intraoperative imaging, spine surgery, medical simulation systems, tissue
 engineering and cell therapy, remote monitoring, wireless diagnostics,
 internet healthcare and other diagnostic and therapeutic technologies.
 Confirmed presenters to date include:
 
     *  Accuray Oncology -- stereotactic radiosurgery/radiotherapy for
        treatment of solid cancers
     *  A-Med Systems, Inc. -- circulatory support for cardiac surgery and
        interventions
     *  American OsteoMedix -- controlled delivery for osteoplasty
     *  Atherotech -- lipid panel for substantially improving the
        identification of cardiovascular disease risk
     *  Bacchus Vascular Inc. -- alternative techniques and devices for
        percutaneous venous and arterial thrombectomy
     *  BioHeart, Inc. --genotyping for heart muscle regeneration
     *  Boston Innovative Optics - innovative corneal implant compatible with
        LASIK
     *  Boston Medical Technologies, Inc. -- non-invasive method for testing
        heart rate variability
     *  Cardio-optics Inc. -- visualization technology to enable real-time
        imaging of tissues normally obscured by blood
     *  CardioStream Corporation -- diagnostic and therapeutic devices for
        detection and treatment of vulnerable plaque
     *  Converge Medical -- anastomotic coupling technology
     *  Corazon Technologies, Inc. -- demineralization techniques
     *  Cortek, Inc. -- lumbar and cervical spinal fusion technologies
     *  Cryovascular Systems, Inc. -- catheter system to prevent post
        angioplasty/stent placement coronary artery restenosis
     *  Derma Sciences -- wound management, wound closure and catheter
        securement
     *  Endologix -- minimally invasive stent technology for abdominal aortic
        aneurysm
     *  ExoGenesis Biomedical Corporation -- gas cluster ion beam processing
        for surface modification of implantable medical devices
     *  FireLogic, Inc. -- wireless applications for accelerating clinical
        trials and managing treatment outcomes
     *  First Circle Medical -- novel platform for treatment of Hepatitis C
     *  Fossa Industries, Inc. -- cost-effective management of urinary
        lithiasis
     *  Hamilton Thorne Biosciences -- reproductive cell analysis systems
     *  Hayes Medical, Inc. -- orthopaedic implant technologies
     *  IDev Technologies, Inc. -- minimally invasive interventional
        radiology/vascular surgery technologies
     *  ImPres Medical, Inc. -- platform technology for management of
        gynecologic disorders, including abnormal uterine bleeding
     *  Integrated Sensing Systems -- pressure and flow sensing systems for
        vascular and other applications
     *  Medical Simulation Corporation -- technology for interactive training
        of healthcare professionals in state-of-the-art medical procedures
     *  MedLink Europe -- medical device supply chain management
     *  Metasensors, Inc. -- diagnostic/monitoring products based on gas
        flowing in microfluidic elements
     *  MicroCHIPS, Inc. -- microchip devices for drug delivery and sensing
        applications
     *  Nervation Ltd. -- polyurethane-based vascular graft devices for the
        treatment of late-stage cardiovascular disease
     *  NeuroVision Inc. -- non-invasive neural treatments for improvement of
        vision
     *  Novadaq Technologies Inc. -- intraoperative cardiac monitoring
     *  Odin Medical Technologies -- intraoperative MRI systems for
        neurosurgery
     *  Osiris Therapeutics, Inc. -- stem cells used for cellular therapy for
        damaged and diseased tissues
     *  Percardia -- stent blood to ventricle alternative to coronary bypass
     *  PRISMedical Corporation -- disposable devices for point-of-use
        preparation and delivery of fluid therapies
     *  Replication Medical -- spinal nucleus replacement device
     *  Sensatex/LifeLink -- "SmartShirt"-a wireless device for remote
        monitoring
     *  Spectrasonics Imaging, Inc. -- high intensity focused ultrasound (HIFU)
        therapy and tissue parameter imaging
     *  Spine Solutions -- total disc replacement prosthesis
     *  Spine-issimus Ltd -- new technology for treatment of back, knee and
        arthritic pain
     *  SuturTek Incorporated -- "Safe-Suturing" closure technology
     *  Tensegra, Inc. -- artificial disc replacement
     *  Tissue Transformation Technologies -- cell-based in vitro models for
        research, drug metabolism, toxicity and compound screening
     *  TissueLink Medical, Inc. -- hemostasis and anastomosis device
     *  VenPro Corporation -- surgical and percutaneous management of chronic
        venous insufficiency
     *  VSM MedTech Ltd. -- devices for improved vital signs monitoring
     *  X-Site Medical, LLC -- arteriotomy closure system
     *  Yoreh Bio Ltd. -- platform technology for cancer diagnostics and
        therapeutics
 
     "The interests of business development, licensing, joint venture,
 acquisition and investment will be well served by attendance at this meeting,"
 reports Sharon O'Reilly, President of Medtech Insight. "The technologies of
 these innovative companies are at the right stage of development for lucrative
 partnering arrangements."
     The "Investment In Innovation" (IN3) conference, which is co-sponsored by
 Arthur Anderson Corporate Finance, Prism Venture Partners, Advanced Technology
 Ventures, Battelle Memorial Institute, MEDMARC, The Patterson Group, ZEVEX,
 and The MedTech Group, is designed for senior executives from the medical
 device and biotech industry, investment bankers and venture capitalists to
 gain exposure to early stage medical technology companies for the purpose of
 investment, acquisition and/or strategic partnering.
     Keynote presentations will be given by James E. Nicholson, Chairman & CEO,
 Cortek, Inc.; Founder, Mitek Surgical Products, Innovasive Devices, Cortek,
 Inc., and Winnipesaukee Investor Group (WIG), on "The Genesis of a Startup
 Medical Venture", and Sharon O'Reilly, President, Medtech Insight LLC, on
 "Medical Technology in the New Millennium." An additional keynote presenter
 will be announced at a later date.
     On-demand viewing of company presentations from Medtech Insight's January
 2001 "Investment In Innovation" conference can be purchased and accessed
 through the Medtech Insight website, at www.medtechinsight.com.
 
     Medtech Insight is the publisher of "Medtech Insight" (formerly
 "BioMaterials & Surgery"), a monthly newsletter designed to keep medical
 device executives up-to-date on the latest discoveries, trends and innovations
 in the medical device industry. The company also publishes analyses of medical
 technology markets through its Reports group, and provides utilization
 database and other content for the medical technology marketplace. For more
 information on Medtech Insight, please contact Scott Pantel at (714) 969-7648
 or by email at scott@medtechinsight.com, or visit the web at
 http://www.medtechinsight.com.  Details on the upcoming IN3 conference in
 Boston are available at http://www.medtechinsight.com/in3-02.html.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X37527478
 
 SOURCE  Medtech Insight